Botanical extract (mixture) · Fact sheet
Ashwagandha
Also known as Withania somnifera
Ashwagandha is a botanical extract with small trials suggesting stress and sleep benefits. Preparations vary, and drowsiness, gastrointestinal effects, thyroid concerns, and rare liver-injury reports complicate broad wellness claims.
What is Ashwagandha?
Ashwagandha is a plant, not a single molecule or peptide. Root and leaf preparations contain mixtures of constituents, so product-specific results should not be assigned to all extracts.
Benefits & claims
Stress relief, sleep, lower cortisol, and testosterone-related claims are common. A change in a stress questionnaire or hormone does not establish benefit for every associated condition.
What the evidence supports
- Some short trials suggest improvements in stress or sleep with specific preparations.
- Evidence does not establish a universal anxiety treatment, reliable hormonal enhancement, or long-term safety.
Research areas
- Perceived stress
- Sleep
- Stress-related hormone measures
Dosage & frequency
Human study contextA stress trial used a defined root extract. That research amount cannot be assumed to apply to generic root powder or all commercial extracts.
Randomized chronic-stress trial
64 adults reporting chronic stress
- Amount
- 300 mg full-spectrum root extract per dose
- Frequency
- Twice daily for 60 days
- Route studied or labeled
- Oral
Defined extract and stress measures; not interchangeable with generic powders.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- Root-only and root-plus-leaf extracts can differ in constituents and concentration.
Interactions & precautions
- NCCIH flags possible interactions with thyroid hormone, sedatives, immunosuppressants, and medicines for diabetes or blood pressure.
What is still unresolved
- Long-term safety and effects across different extracts are uncertain.
Side effects & risks
- Drowsiness, stomach upset, diarrhea, and vomiting are possible.
- Published case reports describe liver injury; they do not measure how often it occurs.
- Thyroid, autoimmune, pregnancy, and medication-interaction concerns are described by NCCIH.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Early human evidenceA 64-person trial found lower stress scores with a particular root extract over 60 days. Small samples, varied preparations, and short follow-up limit generalization.
Studies
64-person, 60-day randomized trial of a specific extract.
Five clinical cases; causality assessment, co-exposures, and follow-up limitations.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
Explore 3 sourced accounts by reported effect.
Energy: reported experiences
Early calm followed by emotional flatness
An author described less stress at first, then loss of joy, motivation and sexual interest over several months. They reported some improvement a week after stopping.
Reported use in this account
- Product
- Ashwagandha supplement; extract or whole-root formulation not stated
- Amount
- 3,600 mg
- Frequency
- Daily
- Route
- Not specified clearly
- Duration
- About five months
This self-assessment does not establish a clinical diagnosis, causation or permanent effects.
Read the original accountMood: reported experiences
Early calm followed by emotional flatness
An author described less stress at first, then loss of joy, motivation and sexual interest over several months. They reported some improvement a week after stopping.
Reported use in this account
- Product
- Ashwagandha supplement; extract or whole-root formulation not stated
- Amount
- 3,600 mg
- Frequency
- Daily
- Route
- Not specified clearly
- Duration
- About five months
This self-assessment does not establish a clinical diagnosis, causation or permanent effects.
Read the original accountNo perceived anxiety relief
A commenter described no effect after months of trying several formulations, including KSM-66.
Reported use in this account
- Product
- Ashwagandha products, including a product called KSM-66
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Months
Product content, baseline symptoms and other treatments were not verified.
Read the original accountLower perceived stress, but feeling emotionally flat
A person described less stress after starting ashwagandha alongside feeling neither happy nor sad and unusually emotionally neutral.
Amount, frequency, route and duration could not be confirmed for this account.
This selected account does not establish a diagnosis, mechanism, prevalence or permanent effect. Formulation, other exposures and baseline symptoms were not independently assessed.
Read the emotional-flatness reportSexual function: reported experiences
Early calm followed by emotional flatness
An author described less stress at first, then loss of joy, motivation and sexual interest over several months. They reported some improvement a week after stopping.
Reported use in this account
- Product
- Ashwagandha supplement; extract or whole-root formulation not stated
- Amount
- 3,600 mg
- Frequency
- Daily
- Route
- Not specified clearly
- Duration
- About five months
This self-assessment does not establish a clinical diagnosis, causation or permanent effects.
Read the original accountNo clear change: reported experiences
No perceived anxiety relief
A commenter described no effect after months of trying several formulations, including KSM-66.
Reported use in this account
- Product
- Ashwagandha products, including a product called KSM-66
- Amount
- Not specified clearly
- Frequency
- Not specified clearly
- Route
- Not specified clearly
- Duration
- Months
Product content, baseline symptoms and other treatments were not verified.
Read the original accountApproval status
Ashwagandha has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.
Supplement research is not FDA drug approval
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Which preparations reproduce trial results
- Long-term safety and the frequency of liver injury
- Meaningful hormonal or functional outcomes
Summary
Evidence does not establish a universal anxiety treatment, reliable hormonal enhancement, or long-term safety.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- nihNCCIH: ashwagandha usefulness and safety
Evidence limitations, gastrointestinal effects, and condition-specific safety concerns.
- pubmedAshwagandha-associated liver injury case series
Five clinical cases; causality assessment, co-exposures, and follow-up limitations.